Avista Healthcare Partners

What Avista Healthcare Partners does

Avista Healthcare Partners is a New York-based private equity firm founded in 2005 as a spin-out from DLJ Merchant Banking. The firm invests exclusively in healthcare, targeting mid-sized companies with experienced management teams, stable cash flows, and durable growth prospects across six subsectors: outsourced pharma and medtech services, consumer healthcare, medical devices and medtech, specialty and generic pharmaceuticals, distribution and diagnostics, and healthcare technology. Since inception, Avista has deployed over $9 billion into 50 platform investments and supported more than 100 add-on acquisitions across its portfolio. The firm is differentiated by a network of 12 Healthcare Strategic Executives who provide sector insight, operational oversight, and senior counsel alongside the investment team of approximately 25 professionals.

The firm's business model is that of a sector-focused private equity sponsor. Avista raises capital from institutional limited partners into dedicated healthcare funds, earns management fees on committed and invested capital, and realizes carried interest through portfolio company exits via mergers, acquisitions, or public offerings. Deal sourcing is relationship-driven, leveraging healthcare industry relationships developed by both the investment team and the Strategic Executives. The firm also supports add-on acquisitions through portfolio companies, exemplified by GCM's January 2025 acquisition of Precision Swiss Products and Avista's June 2025 acquisition of EBI (the 50th platform investment).

Avista is led by Managing Partner and CEO David Burgstahler and Chairman and Co-Head of the Investment Committee Thompson Dean, with Ben Silbert (a founding member since 2005) serving as Managing Director and General Counsel. The firm maintains a single New York headquarters at 65 East 55th Street, 18th Floor, and reports a global investment footprint despite a U.S. operating base. As of 2025–2026, the firm is actively expanding its investment team and has built out an Investor Relations function, consistent with ongoing fundraising and platform activity. Revenue, AUM, and fund-size figures are not publicly disclosed.

Name

Avista Healthcare Partners

Legal name

Avista Capital Holdings, L.P.

Website

https://avistahealthcare.com

Company type

Private

Founded year

2005

Operating status

Operating

Short description

Avista Healthcare Partners is a New York-based private equity firm founded in 2005 that invests exclusively in mid-sized healthcare companies, having deployed over $9 billion across 50 platform investments and supported 100+ add-on acquisitions in six healthcare subsectors.

Ownership category

akta.pro rank

Product category

Healthcare Private Equity

NAICS

Portfolio Management and Investment Advice (52394), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)

SIC

Investment Advice (6282)

akta.pro primary industry

Multi-Sector / Generalist Growth Equity (FSANACAO)

Keywords

• Healthcare private equity
• Growth capital investments
• Buyout investments
• Portfolio company management
• Healthcare investments

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Private Equity Investment Returns: Avista generates returns through equity investments in healthcare companies, realizing gains through portfolio company exits via mergers, acquisitions, or public offerings. The firm also earns management fees and carried interest from its private equity funds.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Avista Healthcare Partners is a private equity firm that invests growth equity in leading healthcare companies, providing capital, operational expertise through Healthcare Strategic Executives, and flexible financing solutions to mid-sized companies across six healthcare subsectors. The firm generates returns through management fees, carried interest, and exits of its 50+ portfolio companies via mergers, acquisitions, or public offerings.

Product overview

Avista Healthcare Partners is a private equity firm, not a product company. The company invests capital in healthcare companies and provides operational expertise, strategic guidance, and flexible financing solutions to support growth and value creation in portfolio companies. The firm does not develop, manufacture, or sell products or technology solutions; rather, it acquires equity stakes in healthcare businesses across subsectors including outsourced pharma & medtech services, consumer healthcare, medical devices & medtech, specialty & generic pharmaceuticals, distribution & diagnostics, and healthcare technology. Avista's offering consists of investment management services, not technology products.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Private Equity Investment Funds Pooled private equity funds that invest growth equity in mid-sized healthcare companies across six healthcare subsectors, targeting returns through management fees, carried interest, and portfolio company exits. Aimed at institutional limited partners seeking healthcare-specialist exposure.

Quantifiable outcome

• 50 platform healthcare investments completed since founding in 2005
• +2 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• New Mountain Capital: A growth-oriented private equity firm with a longstanding healthcare services and healthcare IT focus. Comparable to Avista in mid-sized healthcare company investing and active operating partnership model.
• Linden Capital Partners: A healthcare-only middle-market private equity firm investing in mid-sized healthcare businesses across services, products, and distribution. Closest direct competitor to Avista in scale, sector focus, and mid-market deal size.
• TPG Capital (Healthcare): TPG operates a dedicated healthcare practice alongside its flagship buyout funds, investing across healthcare services, devices, and life sciences. Direct comparable to Avista in healthcare specialization with greater AUM and broader sub-sector reach.
• Bain Capital Life Sciences: The life sciences-focused investment arm of Bain Capital targeting healthcare and biotech investments across stages and structures. Comparable to Avista in dedicated healthcare deployment with growth equity orientation, though larger and broader in mandate.
• GTCR LLC: Chicago-based private equity firm with deep healthcare expertise and a Leaders Strategy approach that pairs operating executives with portfolio companies. Highly comparable to Avista in operating-oriented healthcare investing with mid-market deal focus.
• KKR Healthcare Strategic Growth: KKR's healthcare-focused growth equity strategy investing in mid-to-large healthcare companies. Comparable to Avista in sector dedication, growth equity orientation, and operating value-add approach, though at larger fund scale.
• Welsh, Carson, Anderson & Stowe: One of the longest-tenured healthcare-focused private equity firms in the US, deploying dedicated healthcare capital across services, devices, and technology. Directly comparable to Avista in sector focus, mid-sized company strategy, and operating-oriented value creation model.

Broad incumbents

• CVC Capital Partners: Global private equity firm with European and US healthcare investing activity that overlaps with Avista's medical device and healthcare services sub-sectors. A broad incumbent relative to Avista's US-centric, sector-specialized focus.
• Clayton, Dubilier & Rice: Large-cap private equity firm with healthcare services and medical products investing alongside other verticals. Operates as a broad incumbent that periodically competes with Avista on larger healthcare targets.
• Carlyle Group: Global investment firm with a dedicated US Buyout healthcare practice and substantial healthcare AUM. A larger incumbent operating across healthcare subsectors that overlap materially with Avista's targeted verticals.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/avista-capital-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles27 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avista Healthcare Partners